TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17881750

Group type: EXPERIMENTAL
Intervention: Repeat doses of antenatal corticosteroids (11.4 mg of betamethasone, intramuscular injection, repeated weekly if at risk for preterm delivery)
Number of subjects: 1085

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 1085

Group type: EXPERIMENTAL
Intervention: Repeat doses of antenatal corticosteroids
Number of subjects: 1085

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1085
Study: 16541760

Group type: EXPERIMENTAL
Intervention: Frequent disinfection by antiseptics
Number of subjects: 97

Group type: COMPARATOR
Intervention: Surgical dressing without frequent disinfection
Number of subjects: 97
Study: 12548591

Group type: EXPERIMENTAL
Intervention: AMGN-0007 (subcutaneously)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Pamidronate (90 mg intravenously)
Number of subjects: 54
Study: 11780252

Group type: EXPERIMENTAL
Intervention: Polyphenol tablet, 3 times a day for 2 weeks, followed by 6 weeks of continued use for group B.
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo given to contrast group.
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Polyphenol tablet, after stopping use for 3 weeks.
Number of subjects: 150
Study: 8780281

Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Spinal Anesthesia (SA) with IV propofol sedation
Number of subjects: 122
Study: 1293241

Group type: EXPERIMENTAL
Intervention: SMS 201‐995 therapy (100 micrograms t.d.s. for 5 days)
Number of subjects: 12
Study: 6539322

Group type: EXPERIMENTAL
Intervention: 100 ml of 25% albumin solution
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 200 ml of 25% albumin solution
Number of subjects: 26

Group type: COMPARATOR
Intervention: 100 ml of 0.9% saline
Number of subjects: 26

Group type: COMPARATOR
Intervention: 200 ml of 0.9% saline
Number of subjects: 26
Study: 31014399

Group type: EXPERIMENTAL
Intervention: High-dose IFNα
Number of subjects: 35

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: DC vaccine
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Immune biomarker analysis
Number of subjects: 35
Study: 27986795

Group type: EXPERIMENTAL
Intervention: Tuned waveform (3.5 ms time constant based)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Fixed tilt (50/50%)
Number of subjects: 91
Study: 25496405

Group type: EXPERIMENTAL
Intervention: Rituximab infusion at a weekly dose of 375 mg/m2 for 4 weeks plus oral daily prednisolone
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Rituximab infusion
Number of subjects: 7
Study: 23468513

Group type: EXPERIMENTAL
Intervention: Overlapping drug-eluting stents (R-ZES or R-ZES/other DES)
Number of subjects: 5130
Study: 21114550

Group type: EXPERIMENTAL
Intervention: Cobalt (Co) 59mg intramuscular injection diluted in 5ml 0.9% saline solution twice a day
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (5ml 0.9% saline solution intramuscular injection twice a day)
Number of subjects: 10
Study: 18095751

Group type: EXPERIMENTAL
Intervention: Mucoadhesive patch containing citrus oil and magnesium salts
Number of subjects: 48

Group type: COMPARATOR
Intervention: Oral solution containing benzocaine and compound benzoin tincture
Number of subjects: 48
Study: 17602057

Group type: EXPERIMENTAL
Intervention: Total Pancreatectomy (TP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extended Lymph Node Dissection (ELND)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Major Arterial Resection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Portal and/or Mesenteric Venous Resection
Number of subjects: 0
Study: 15014007

Group type: EXPERIMENTAL
Intervention: ACA125 vaccine
Number of subjects: 119
Study: 11500526

Group type: EXPERIMENTAL
Intervention: Leptin 0.3 mg/kilogram subcutaneously for 6 days
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 9406129

Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 8307916

Group type: EXPERIMENTAL
Intervention: endoscopic sclerotherapy along with ranitidine 300 mg daily
Number of subjects: 31

Group type: COMPARATOR
Intervention: endoscopic sclerotherapy alone
Number of subjects: 31
Study: 3500688

Group type: EXPERIMENTAL
Intervention: 5-hydroxytryptophan (200 mg, orally)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30062794

Group type: EXPERIMENTAL
Intervention: Psyllium 7 g t.d.s.
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 27656054

Group type: EXPERIMENTAL
Intervention: Apical clearing technique (ACT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional apical preparation (CAP)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both ACT and CAP
Number of subjects: 20
Study: 26022102

Group type: EXPERIMENTAL
Intervention: Modification of movement patterns augmented by motion-sensor movement biofeedback plus guidelines-based medical or physiotherapy care
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo (wearing the motion-sensors without biofeedback) plus guidelines-based medical or physiotherapy care
Number of subjects: 112
Study: 22747899

Group type: EXPERIMENTAL
Intervention: FENO-driven therapy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standard management group (control)
Number of subjects: 90
Study: 20185272

Group type: EXPERIMENTAL
Intervention: HARP program
Number of subjects: 80

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 80
Study: 18237706

Group type: EXPERIMENTAL
Intervention: Suture anchor fixation
Number of subjects: 14

Group type: COMPARATOR
Intervention: Suture fixation to an intact labrum
Number of subjects: 14
Study: 16357109

Group type: EXPERIMENTAL
Intervention: Palmtop-assisted self-interviewing (PASI)
Number of subjects: 1283

Group type: COMPARATOR
Intervention: Audio-computer-assisted self-interviewing (ACASI)
Number of subjects: 1283

Group type: COMPARATOR
Intervention: Face-to-face interviews
Number of subjects: 1283
Study: 14582037

Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 3577

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3577
Study: 10972410

Group type: EXPERIMENTAL
Intervention: Imagined movement at slow speed
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Imagined movement at fast speed
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Physical performance at slow speed
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Physical performance at fast speed
Number of subjects: 74

Group type: COMPARATOR
Intervention: No-practice control task
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Imagined movement (both slow and fast)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Overt vocalization of words
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Imagined movement at slow speed (Experiment 2)
Number of subjects: 74
Study: 8666450

Group type: EXPERIMENTAL
Intervention: Transmandibular implant group
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Endosseous implant group
Number of subjects: 95

Group type: COMPARATOR
Intervention: Control group (conventional complete dentures)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Overall satisfaction, complaints, and subjective chewing ability
Number of subjects: 95
Study: 1730190

Group type: EXPERIMENTAL
Intervention: Cefotaxime 1 g i.v. t.i.d.
Number of subjects: 34

Group type: COMPARATOR
Intervention: Ceftriaxone 2 g every 24 hr
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Cefotaxime and Ceftriaxone (both groups)
Number of subjects: 34
Study: 4053132

Group type: EXPERIMENTAL
Intervention: Thiazide diuretic-based antihypertensive therapy regimens
Number of subjects: 72
Study: 31626127

Group type: EXPERIMENTAL
Intervention: Rational-Emotive Behavior Therapy (REBT) for 10 weeks with 8 weeks follow-up
Number of subjects: 154

Group type: COMPARATOR
Intervention: No-treatment group
Number of subjects: 154
Study: 28726525

Group type: EXPERIMENTAL
Intervention: Alcohol/marijuana education
Number of subjects: 153

Group type: COMPARATOR
Intervention: Motivational interviewing (MI)
Number of subjects: 153
Study: 26804064

Group type: EXPERIMENTAL
Intervention: Stepwise multidisciplinary intervention (STA OP!)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Control condition (general nursing skills, dementia management, and pain training)
Number of subjects: 288
Study: 23934088

Group type: EXPERIMENTAL
Intervention: 5% potassium nitrate as a desensitizing agent 30 min before bleaching with 28% hydrogen peroxide activated by LED
Number of subjects: 32

Group type: COMPARATOR
Intervention: Glycerin as a placebo
Number of subjects: 32
Study: 22529265

Group type: EXPERIMENTAL
Intervention: Bevacizumab (BV) with gemcitabine and carboplatin (GC)
Number of subjects: 484

Group type: COMPARATOR
Intervention: Placebo (PL) with gemcitabine and carboplatin (GC)
Number of subjects: 484
Study: 20517330

Group type: EXPERIMENTAL
Intervention: Lipid-soluble vitamin supplementation
Number of subjects: 1078
Study: 18480825

Group type: EXPERIMENTAL
Intervention: Testosterone treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no testosterone treatment)
Number of subjects: 0
Study: 16164657

Group type: EXPERIMENTAL
Intervention: Ferumoxytol (4 doses of 255 mg iron in 2 weeks or 2 doses of 510 mg iron in 1 to 2 weeks)
Number of subjects: 21
Study: 12553779

Group type: EXPERIMENTAL
Intervention: Message appeals tailored to low idiocentrics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Message appeals tailored to high idiocentrics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Message appeals for low self-monitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Message appeals for high self-monitors
Number of subjects: 0
Study: 11401916

Group type: EXPERIMENTAL
Intervention: 1.0 g of DFMO
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 0.5 g of DFMO
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 9462972

Group type: EXPERIMENTAL
Intervention: Triflusal treatment
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 73
Study: 1337459

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 28

Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 28
Study: 3896411

Group type: EXPERIMENTAL
Intervention: Naltrexone 100 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Naltrexone 200 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Naltrexone 300 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Acetaminophen placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Naltrexone (all doses combined)
Number of subjects: 8
Study: 29772111

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate (CC) 50 mg
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Human chorionic gonadotropin (hCG) 5000 IU injections twice weekly
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Combination of Clomiphene citrate and hCG (CC + hCG)
Number of subjects: 282
Study: 27578477

Group type: EXPERIMENTAL
Intervention: 5 μg tiotropium
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: 50 μg glycopyrronium
Number of subjects: 13
Study: 24573184

Group type: EXPERIMENTAL
Intervention: Estradiol (E2)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Testosterone (T)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 22817672

Group type: EXPERIMENTAL
Intervention: Preoperative warming with a forced air warming device
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Warmed intraoperative irrigation solutions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both preoperative warming and warmed intraoperative irrigation solutions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neither intervention (control group)
Number of subjects: 0
Study: 20405054

Group type: EXPERIMENTAL
Intervention: Doxycycline (200 mg/day) alone for 6 weeks
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Doxycycline (200 mg/day) + Ivermectin (150 microg/kg) at +4 months
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Doxycycline only
Number of subjects: 172

Group type: COMPARATOR
Intervention: Ivermectin only
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Doxycycline (200 mg/day)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Doxycycline and Ivermectin
Number of subjects: 172
Study: 18712044

Group type: COMPARATOR
Intervention: Amlodipine 5 mg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg
Number of subjects: 72
Study: 15964448

Group type: EXPERIMENTAL
Intervention: Doxycycline (200 mg per day for 8 weeks)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 12574183

Group type: EXPERIMENTAL
Intervention: Troglitazone (Tgz) 600 mg/d for 3 months
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group (OBW, N=13)
Number of subjects: 10
Study: 12389267

Group type: EXPERIMENTAL
Intervention: Stress-reduction psychoeducation intervention
Number of subjects: 0
Study: 10645516

Group type: EXPERIMENTAL
Intervention: Policosanol (10 mg/day)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Acipimox (750 mg/day)
Number of subjects: 63
Study: 7564934

Group type: EXPERIMENTAL
Intervention: Version I (n = 58) - trade-off with increasingly negative descriptions of outcomes of resuscitation
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Version II (n = 47) - trade-off with increasingly positive descriptions of outcomes of resuscitation
Number of subjects: 105
Study: 2155650

Group type: EXPERIMENTAL
Intervention: Full series method of reading chest radiographs
Number of subjects: 33

Group type: COMPARATOR
Intervention: Side by side pairs method
Number of subjects: 33

Group type: COMPARATOR
Intervention: Two separate randomly ordered films method
Number of subjects: 33
Study: 6772302

Group type: EXPERIMENTAL
Intervention: GTNO
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 10
Study: 6550482

Group type: EXPERIMENTAL
Intervention: Cefamandole alone
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Cefamandole plus tobramycin
Number of subjects: 80

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Cefamandole-treated patients
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Vancomycin-containing sera
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Cefamandole-plus-tobramycin-containing sera
Number of subjects: 80
Study: 28117627

Group type: EXPERIMENTAL
Intervention: Manual-based treatment for school refusal
Number of subjects: 112

Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 112
Study: 27895297

Group type: EXPERIMENTAL
Intervention: Adaptive trial design with subgroup selection based on onset-to-randomization time
Number of subjects: 382

Group type: COMPARATOR
Intervention: Fixed trial design
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Adaptive trial design with subgroup selection based on arterial occlusive lesion and time
Number of subjects: 382
Study: 24347426

Group type: EXPERIMENTAL
Intervention: Raloxifene 120 mg/day for 1 month
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Estrogen (E₂) 4 mg/day for 1 month
Number of subjects: 28

Group type: COMPARATOR
Intervention: GH treatment alone (0.5 mg/day) for 1 month
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: GH treatment with raloxifene (60 mg/day) for 1 month
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: GH treatment with estrogen (2 mg/day) for 1 month
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Raloxifene administration
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Estrogen administration
Number of subjects: 28
Study: 22405235

Group type: EXPERIMENTAL
Intervention: Episodic training
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Episodic training with a secondary task (mental arithmetic task)
Number of subjects: 60
Study: 21098449

Group type: EXPERIMENTAL
Intervention: varespladib 500 mg PO BID
Number of subjects: 144

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 144
Study: 18295412

Group type: EXPERIMENTAL
Intervention: Traumatic film (1-hour combat footage)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Neutral film (1-hour oil painting tutorial)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Traumatic film
Number of subjects: 10
Study: 15698697

Group type: COMPARATOR
Intervention: Principal component analysis applied to kinematic and kinetic waveforms of lifting technique.
Number of subjects: 16
Study: 14623668

Group type: EXPERIMENTAL
Intervention: Cycling on an ergometer bicycle until the pulse rate reached a steady state level and a score of 14 to 17 on Borg's Ratio of Perceived Exertion scale
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 24
Study: 11025624

Group type: EXPERIMENTAL
Intervention: Cyproheptadine
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Combination of cyproheptadine and propranolol
Number of subjects: 259

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 259
Study: 9002796

Group type: EXPERIMENTAL
Intervention: Listerine Antiseptic (LA)
Number of subjects: 25

Group type: COMPARATOR
Intervention: 5% hydroalcohol control rinse
Number of subjects: 25
Study: 1335645

Group type: EXPERIMENTAL
Intervention: Oral administration of live attenuated hepatitis A vaccine at doses of 10(4), 10(5), 10(6), and 10(7) TCID50
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intramuscular administration of live attenuated hepatitis A vaccine at doses of 10(6) and 10(7) TCID50
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 6363896

Group type: EXPERIMENTAL
Intervention: Human (semisynthetic) insulin
Number of subjects: 21

Group type: COMPARATOR
Intervention: Porcine insulin
Number of subjects: 21
Study: 31038125

Group type: COMPARATOR
Intervention: Alcoholic men (ALCM)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Alcoholic women (ALCW)
Number of subjects: 88
Study: 29493347

Group type: EXPERIMENTAL
Intervention: Maximal strength training (MST)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional physiotherapy (CP)
Number of subjects: 60
Study: 27544023

Group type: EXPERIMENTAL
Intervention: Ahmed‐FP7 implant
Number of subjects: 238

Group type: COMPARATOR
Intervention: Baerveldt‐350 implant
Number of subjects: 238
Study: 24549550

Group type: EXPERIMENTAL
Intervention: Home exercise program with minimal supervision (n=120)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Attention control group (n=112)
Number of subjects: 232
Study: 22221551

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sclerotherapy with 75% glucose solution
Number of subjects: 30
Study: 20929599

Group type: EXPERIMENTAL
Intervention: Extrafine BDP, 100 μg, b.i.d.
Number of subjects: 14

Group type: COMPARATOR
Intervention: Nonextrafine BDP, 250 μg, b.i.d.
Number of subjects: 14
Study: 19100092

Group type: EXPERIMENTAL
Intervention: Antiarrhythmic drugs (AADs) for 3 months
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Total recurrence rate
Number of subjects: 74
Study: 16284568

Group type: EXPERIMENTAL
Intervention: Laminectomy electrode
Number of subjects: 24

Group type: COMPARATOR
Intervention: Percutaneous electrode
Number of subjects: 24
Study: 12353945

Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 4

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4
Study: 10774084

Group type: EXPERIMENTAL
Intervention: Baseline studies prior to randomisation to antimalarial prophylactic regimens
Number of subjects: 705
Study: 8869674

Group type: EXPERIMENTAL
Intervention: Group 1 (lungs deflated)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Group 2 (static inflation with PEEP = 5 cmH2O and FIO2 = 1.0)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Group 3 (static inflation with PEEP = 5 cmH2O and FIO2 = 0.21)
Number of subjects: 30
Study: 1843523

Group type: EXPERIMENTAL
Intervention: DDD pacing
Number of subjects: 16

Group type: COMPARATOR
Intervention: VVI pacing
Number of subjects: 16
Study: 6349608

Group type: EXPERIMENTAL
Intervention: Methazolamide (150 mg/d)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Acetazolamide (500 mg/d)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Methazolamide (100 mg/d) at low altitude
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Methazolamide
Number of subjects: 20
Study: 28416515

Group type: EXPERIMENTAL
Intervention: Low FODMAP diet
Number of subjects: 67

Group type: COMPARATOR
Intervention: Traditional IBS diet
Number of subjects: 67
Study: 28247654

Group type: EXPERIMENTAL
Intervention: Standard treatment for acute serous and purulent pyelonephritis
Number of subjects: 62
Study: 25741619

Group type: COMPARATOR
Intervention: Treadmill training with 0% load
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treadmill training with 5% load
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treadmill training with 10% load
Number of subjects: 0
Study: 23927490

Group type: EXPERIMENTAL
Intervention: Decision Aid (DA) about starting statins
Number of subjects: 103

Group type: COMPARATOR
Intervention: Usual Care (Control)
Number of subjects: 103
Study: 20159716

Group type: EXPERIMENTAL
Intervention: General-epidural anesthesia combined with PCEA (GE group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: General anesthesia (G group)
Number of subjects: 100
Study: 18575849

Group type: EXPERIMENTAL
Intervention: risperidone
Number of subjects: 25

Group type: COMPARATOR
Intervention: haloperidol
Number of subjects: 25
Study: 16183220

Group type: EXPERIMENTAL
Intervention: Testosterone gel (10mg per day)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 12532366

Group type: EXPERIMENTAL
Intervention: TTouch (5-min intervention)
Number of subjects: 93

Group type: COMPARATOR
Intervention: No-touch control group
Number of subjects: 93
Study: 10989855

Group type: EXPERIMENTAL
Intervention: Surface laryngeal electromyography
Number of subjects: 10

Group type: COMPARATOR
Intervention: Intramuscular laryngeal electromyography
Number of subjects: 10
Study: 8894360

Group type: EXPERIMENTAL
Intervention: Aceclofenac (AC)
Number of subjects: 292

Group type: COMPARATOR
Intervention: Tenoxicam (TX)
Number of subjects: 292